Skip to main content
. 2016 Feb 25;7(13):17074–17086. doi: 10.18632/oncotarget.7717

Figure 2. Immunohistochemical analysis of the expression levels of VEGF, VEGFR2 and CRMP4 in tumor sections from gastric cancer patients.

Figure 2

A. Immunohistochemical detection of VEGF, VEGFR2, and CRMP4 expression levels in tumor and tumor-adjacent tissues collected from gastric cancer patients. B. The relative intensities of VEGF, VEGFR2 and CRMP4 expression in 10 pairs of tumor and tumor-adjacent tissues were evaluated by IPP based on the IHC results. The results analyzed with ANOVA are expressed as means ± SD. The protein expression levels of VEGF and CRMP4 were significantly increased in gastric cancer tissues compared with tumor-adjacent tissues, whereas the VEGFR2 expression levels did not display any significant increase.